Tag: Cancer: Ovarian
Factors Tied to Hormone Therapy Use After Oophorectomy ID’d
Age, education, preventive mastectomy linked to hormone therapy use in BRCA mutation carriers
Most Gynecologic Cancer Therapy Not Tied to Higher COVID-19 Risk
Only recent immunotherapy use linked to death due to COVID-19 in gynecologic oncology patients
J&J Ordered to Pay $2.1 Billion in Talcum Product Lawsuit
Decision reduced by more than half the record award of $4.7 billion made to the women in July 2018
ASCO: At-Home Ovarian, Breast Cancer Genetic Testing Feasible
Testing without the traditional office visits and counseling poses no additional stress to women
Sales of Johnson’s Baby Powder Halted in U.S., Canada
Johnson & Johnson says talc-based powder is safe and will still be sold in other countries
Use of Powder in Genital Area Not Linked to Ovarian Cancer
Frequent versus never use, long-term versus never use not significantly associated with higher risk
Addition of Maintenance Olaparib Slows Advanced Ovarian Cancer
Benefit substantial for homologous-recombination deficiency positive tumors with, without BRCA mutations
Secondary Surgical Cytoreduction Not Superior in Ovarian Cancer
Addition of surgery prior to chemotherapy does not prolong overall survival in recurrent ovarian cancer
CA125 Can Detect Ovarian Cancer in General Practice
And elevated CA125 indicates higher risk for other cancers, especially in women aged ≥50 years
J&J Says No Asbestos Detected in New Tests of Baby Powder
Tests were performed by two third-party laboratories as part of the company's ongoing investigation
